| Hepatitis C reinfection after successful antiviral treatment among people who inject drugs: A meta-analysis B Hajarizadeh, EB Cunningham, H Valerio, M Martinello, M Law, ... Journal of hepatology 72 (4), 643-657, 2020 | 143 | 2020 |
| Toward a more complete understanding of the association between a hepatitis C sustained viral response and cause‐specific outcomes HA Innes, SA McDonald, JF Dillon, S Allen, PC Hayes, D Goldberg, ... Hepatology 62 (2), 355-364, 2015 | 142 | 2015 |
| The risk of hepatocellular carcinoma in cirrhotic patients with hepatitis C and sustained viral response: role of the treatment regimen H Innes, ST Barclay, PC Hayes, A Fraser, JF Dillon, A Stanley, A Bathgate, ... Journal of hepatology 68 (4), 646-654, 2018 | 117 | 2018 |
| Factors associated with spontaneous clearance of chronic hepatitis C virus infection N Bulteel, PP Sarathy, E Forrest, AJ Stanley, H Innes, PR Mills, H Valerio, ... Journal of hepatology 65 (2), 266-272, 2016 | 108 | 2016 |
| Declining hepatitis C virus-related liver disease burden in the direct-acting antiviral therapy era in New South Wales, Australia M Alavi, MG Law, H Valerio, J Grebely, J Amin, B Hajarizadeh, C Selvey, ... Journal of hepatology 71 (2), 281-288, 2019 | 102 | 2019 |
| The contribution of alcohol use disorder to decompensated cirrhosis among people with hepatitis C: an international study M Alavi, NZ Janjua, M Chong, J Grebely, EJ Aspinall, H Innes, HM Valerio, ... Journal of hepatology 68 (3), 393-401, 2018 | 84 | 2018 |
| Mortality in hepatitis C patients who achieve a sustained viral response compared to the general population H Innes, S McDonald, P Hayes, JF Dillon, S Allen, D Goldberg, PR Mills, ... Journal of Hepatology 66 (1), 19-27, 2017 | 71 | 2017 |
| A matched comparison study of hepatitis C treatment outcomes in the prison and community setting, and an analysis of the impact of prison release or transfer during therapy EJ Aspinall, W Mitchell, J Schofield, A Cairns, S Lamond, P Bramley, ... Journal of viral hepatitis 23 (12), 1009-1016, 2016 | 67 | 2016 |
| Association between opioid agonist therapy and testing, treatment uptake, and treatment outcomes for hepatitis C infection among people who inject drugs: a systematic review … J Grebely, L Tran, L Degenhardt, A Dowell-Day, T Santo Jr, S Larney, ... Clinical Infectious Diseases 73 (1), e107-e118, 2021 | 63 | 2021 |
| Progress towards elimination of hepatitis C infection among people who inject drugs in Australia: The ETHOS Engage Study H Valerio, M Alavi, D Silk, C Treloar, M Martinello, A Milat, A Dunlop, ... Clinical infectious diseases 73 (1), e69-e78, 2021 | 63 | 2021 |
| Hepatitis C reinfection following treatment induced viral clearance among people who have injected drugs A Weir, A McLeod, H Innes, H Valerio, EJ Aspinall, DJ Goldberg, ... Drug and alcohol dependence 165, 53-60, 2016 | 54 | 2016 |
| Assessment of the Average Price and Ethanol Content of Alcoholic Beverages by Brand—U nited S tates, 2011 JT DiLoreto, M Siegel, D Hinchey, H Valerio, K Kinzel, S Lee, K Chen, ... Alcoholism: clinical and experimental research 36 (7), 1288-1297, 2012 | 46 | 2012 |
| Expansion of HCV treatment access to people who have injected drugs through effective translation of research into public health policy: Scotland's experience SJ Hutchinson, JF Dillon, R Fox, SA McDonald, HA Innes, A Weir, ... International Journal of Drug Policy 26 (11), 1041-1049, 2015 | 40 | 2015 |
| High hepatitis C treatment uptake among people with recent drug dependence in New South Wales, Australia H Valerio, M Alavi, M Law, S Tillakeratne, J Amin, NZ Janjua, M Krajden, ... Journal of hepatology 74 (2), 293-302, 2021 | 37 | 2021 |
| The contribution of health risk behaviors to excess mortality in American adults with chronic hepatitis C: A population cohort‐study H Innes, A McAuley, M Alavi, H Valerio, D Goldberg, SJ Hutchinson Hepatology 67 (1), 97-107, 2018 | 34 | 2018 |
| The frequency of company-sponsored alcohol brand-related sites on Facebook™–2012 S Nhean, J Nyborn, D Hinchey, H Valerio, K Kinzel, M Siegel, ... Substance use & misuse 49 (7), 779-782, 2014 | 29 | 2014 |
| Australia could miss the WHO hepatitis C virus elimination targets due to declining treatment uptake and ongoing burden of advanced liver disease complications JA Kwon, GJ Dore, B Hajarizadeh, M Alavi, H Valerio, J Grebely, R Guy, ... Plos one 16 (9), e0257369, 2021 | 25 | 2021 |
| Time to detection of hepatitis C virus infection with the Xpert HCV viral load fingerstick point-of-care assay: facilitating a more rapid time to diagnosis J Grebely, B Catlett, I Jayasinghe, H Valerio, B Hajarizadeh, A Verich, ... The Journal of infectious diseases 221 (12), 2043-2049, 2020 | 24 | 2020 |
| Prognosis of 1169 hepatitis C chronically infected patients with decompensated cirrhosis in the predirect‐acting antiviral era SA McDonald, HA Innes, E Aspinall, PC Hayes, M Alavi, H Valerio, ... Journal of viral hepatitis 24 (4), 295-303, 2017 | 24 | 2017 |
| Population impact of direct-acting antiviral treatment on new presentations of hepatitis C-related decompensated cirrhosis: a national record-linkage study SJ Hutchinson, H Valerio, SA McDonald, A Yeung, K Pollock, S Smith, ... Gut 69 (12), 2223-2231, 2020 | 21 | 2020 |
Jason GrebelyProfessor, The Kirby Institute, UNSW SydneyVerified email at kirby.unsw.edu.au
